Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.
作者信息
Chen Lei, Abou-Alfa Ghassan K, Zheng Bo, Liu Jing-Feng, Bai Jian, Du Lu-Tao, Qian Yun-Song, Fan Rong, Liu Xiao-Long, Wu Lin, Hou Jin-Lin, Wang Hong-Yang
机构信息
National Center for Liver Cancer, Shanghai, 210822, China.
International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai, 200438, China.
出版信息
Cell Res. 2021 May;31(5):589-592. doi: 10.1038/s41422-020-00457-7. Epub 2021 Feb 15.
Abstract
摘要
相似文献
1
Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients.用于肝硬化患者肝细胞癌早期检测的循环游离DNA特征的全基因组分析
Cell Res. 2021 May;31(5):589-592. doi: 10.1038/s41422-020-00457-7. Epub 2021 Feb 15.
2
Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.循环游离 DNA 水平对肝细胞癌的诊断价值。
Int J Infect Dis. 2018 Feb;67:92-97. doi: 10.1016/j.ijid.2017.12.002. Epub 2017 Dec 8.
3
The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.使用微创生物标志物进行肝细胞癌的诊断和预后评估。
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188451. doi: 10.1016/j.bbcan.2020.188451. Epub 2020 Oct 14.
4
Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.血小板 RNA 作为生物标志物宝库，可用于区分早期肝细胞癌与潜在的肝硬化结节。
PLoS One. 2021 Sep 1;16(9):e0256739. doi: 10.1371/journal.pone.0256739. eCollection 2021.
5
Circulating Cell-Free DNA and DNA Integrity as Molecular Diagnostic Tools in Hepatocellular Carcinoma.循环游离 DNA 及 DNA 完整性作为肝细胞癌的分子诊断工具。
Am J Clin Pathol. 2022 Aug 4;158(2):254-262. doi: 10.1093/ajcp/aqac037.
6
Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).采用甲基化 CpG 串联扩增和测序（MCTA-Seq）对血浆无细胞 DNA 的组织起源进行全面的 DNA 甲基化分析。
Clin Epigenetics. 2019 Jun 24;11(1):93. doi: 10.1186/s13148-019-0689-y.
7
Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.血浆中肝来源的无细胞核酸：液体活检中的生物学和应用。
J Hepatol. 2019 Aug;71(2):409-421. doi: 10.1016/j.jhep.2019.04.003. Epub 2019 Apr 18.
8
From genome sequencing to the discovery of potential biomarkers in liver disease.从基因组测序到肝脏疾病潜在生物标志物的发现。
BMB Rep. 2020 Jun;53(6):299-310. doi: 10.5483/BMBRep.2020.53.6.074.
9
Cell-specific functions of miRNA in the liver.肝脏中微小RNA的细胞特异性功能。
J Hepatol. 2017 Mar;66(3):655-656. doi: 10.1016/j.jhep.2016.09.015. Epub 2016 Oct 1.
10
DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.DNA 甲基转移酶作为 HCV 相关肝细胞癌的潜在生物标志物。
Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3357-3363. doi: 10.31557/APJCP.2020.21.11.3357.
引用本文的文献
1
Development and clinical applications of liquid biopsy assays in cancer screening.液体活检检测在癌症筛查中的发展与临床应用
Transl Cancer Res. 2025 Jun 30;14(6):3846-3859. doi: 10.21037/tcr-2025-272. Epub 2025 Jun 13.
2
GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing.GUIDE：一项使用靶向DNA甲基化和片段组学测序对胃肠道癌症进行基于血液的早期检测的前瞻性队列研究。
Mol Cancer. 2025 Jun 5;24(1):163. doi: 10.1186/s12943-025-02367-x.
3
Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy.推进肝细胞癌的精准医学：液体活检、免疫微环境、单核苷酸多态性和转化治疗中的当前挑战与未来方向
Hepat Oncol. 2025 Dec;12(1):2493457. doi: 10.1080/20450923.2025.2493457. Epub 2025 Apr 22.
4
The Current Role of Circulating Cell-Free DNA in the Management of Hepatocellular Carcinoma.循环游离DNA在肝细胞癌管理中的当前作用
Cancers (Basel). 2025 Mar 20;17(6):1042. doi: 10.3390/cancers17061042.
5
SERPINI1 serves as a biomarker promoting cell proliferation and invasion in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂I1（SERPINI1）作为一种生物标志物，可促进肝细胞癌的细胞增殖和侵袭。
Cancer Cell Int. 2025 Mar 13;25(1):88. doi: 10.1186/s12935-025-03716-y.
6
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation.循环游离DNA中的5-羟甲基胞嘧啶修饰：癌症检测、监测及预后评估的前沿领域
Biomark Res. 2025 Mar 7;13(1):39. doi: 10.1186/s40364-025-00751-9.
7
Diagnosis of hepatocellular carcinoma using liquid biopsy-based biomarkers: a systematic review and network meta-analysis.基于液体活检生物标志物诊断肝细胞癌：系统评价与网状Meta分析
Front Oncol. 2025 Jan 28;14:1483521. doi: 10.3389/fonc.2024.1483521. eCollection 2024.
8
Cell-free epigenomes enhanced fragmentomics-based model for early detection of lung cancer.基于无细胞表观基因组增强片段组学的肺癌早期检测模型
Clin Transl Med. 2025 Feb;15(2):e70225. doi: 10.1002/ctm2.70225.
9
Integrating multi-omics features enables non-invasive early diagnosis and treatment response prediction of diffuse large B-cell lymphoma.整合多组学特征能够实现弥漫性大B细胞淋巴瘤的非侵入性早期诊断和治疗反应预测。
Clin Transl Med. 2025 Jan;15(1):e70174. doi: 10.1002/ctm2.70174.
10
Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications.肝细胞癌中的液体活检：挑战、进展及临床意义
Clin Mol Hepatol. 2025 Feb;31(Suppl):S255-S284. doi: 10.3350/cmh.2024.0541. Epub 2024 Nov 28.
Zotero 插件